Header cover image

Dutch (AEX) Pharma Industry Analysis

UpdatedFeb 03, 2025
DataAggregated Company Financials
Companies1
  • 7D0%
  • 3M-60.5%
  • 1Y-59.2%
  • YTD-19.3%

In the last week, Pharma has been flat. Unfortunately though, the industry is down 59% over the past 12 months. Looking forward, earnings are forecast to grow by 59% annually.

Industry Valuation and Performance

Has the Dutch Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 03 Feb 2025€37.8m€5.8m-€61,499,953.99n/a-0.6x6.5x
Wed, 01 Jan 2025€46.3m€5.9m-€61,940,571.42n/a-0.7x7.9x
Fri, 29 Nov 2024€92.9m€5.9m-€61,799,018.61n/a-1.5x15.9x
Sun, 27 Oct 2024€93.9m€5.8m-€61,719,579.58n/a-1.5x16.1x
Tue, 24 Sep 2024€94.9m€5.8m-€61,322,845.20n/a-1.5x16.3x
Thu, 22 Aug 2024€70.2m€8.6m-€74,313,120.57n/a-0.9x8.2x
Sat, 20 Jul 2024€73.2m€8.7m-€75,150,822.55n/a-1x8.4x
Mon, 17 Jun 2024€61.2m€8.7m-€75,071,475.11n/a-0.8x7x
Wed, 15 May 2024€71.9m€8.5m-€73,668,542.27n/a-1x8.4x
Fri, 12 Apr 2024€82.9m€8.6m-€74,115,426.83n/a-1.1x9.7x
Sun, 10 Mar 2024€81.1m€12.9m-€69,780,034.70n/a-1.2x6.3x
Tue, 06 Feb 2024€88.1m€12.9m-€69,307,763.94n/a-1.3x6.9x
Thu, 04 Jan 2024€135.1m€12.8m-€68,814,786.00n/a-2x10.6x
Sat, 02 Dec 2023€64.6m€12.8m-€69,184,073.00n/a-0.9x5x
Mon, 30 Oct 2023€111.6m€12.6m-€68,115,840.00n/a-1.6x8.8x
Wed, 27 Sep 2023€117.5m€12.7m-€68,347,732.00n/a-1.7x9.3x
Fri, 25 Aug 2023€124.5m€12.3m-€191,255,891.00n/a-0.7x10.1x
Sun, 23 Jul 2023€164.5m€12.2m-€189,438,683.00n/a-0.9x13.5x
Tue, 20 Jun 2023€183.3m€12.4m-€192,115,932.00n/a-1x14.8x
Thu, 18 May 2023€222.1m€12.2m-€188,800,032.00n/a-1.2x18.3x
Sat, 15 Apr 2023€279.6m€11.9m-€185,057,348.00n/a-1.5x23.5x
Mon, 13 Mar 2023€312.5m€8.8m-€192,115,667.00n/a-1.6x35.4x
Wed, 08 Feb 2023€408.9m€8.8m-€190,750,688.00n/a-2.1x46.7x
Fri, 06 Jan 2023€399.5m€8.8m-€192,284,290.00n/a-2.1x45.3x
Sun, 04 Dec 2022€470.0m€9.1m-€198,579,830.00n/a-2.4x51.5x
Tue, 01 Nov 2022€470.0m€9.1m-€197,617,948.00n/a-2.4x51.8x
Thu, 29 Sep 2022€486.4m€8.7m-€189,571,143.00n/a-2.6x55.9x
Sat, 27 Aug 2022€611.9m€5.5m-€101,923,860.00n/a-6x112.3x
Mon, 25 Jul 2022€779.9m€5.4m-€101,734,870.00n/a-7.7x143.4x
Wed, 22 Jun 2022€959.9m€5.4m-€100,618,857.00n/a-9.5x178.4x
Fri, 20 May 2022€1.1b€5.5m-€102,124,321.00n/a-10.9x203.2x
Price to Earnings Ratio

n/a


Total Market Cap: €1.4bTotal Earnings: €0Total Revenue: €0Total Market Cap vs Earnings and Revenue0%0%0%
Dutch Pharma Industry Price to Earnings3Y Average -2.4x202320242025
Current Industry PE
    There is only one company in the Dutch Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings GrowthThere is insufficient data in this particular industry to determine past growth rates.

Industry Trends

Which industries have driven the changes within the Dutch Healthcare industry?

NL Market4.32%
Healthcare2.69%
Pharma0%0
Pharma0%0
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BAI BenevolentAI€0.322.9%
+€1.1m
-57.5%PS6.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.